Literature DB >> 18419525

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.

Louis B Rice.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18419525     DOI： 10.1086/533452

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  559 in total

1.  Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.

Authors:  Nelson B Olivier; Roger B Altman; Jonas Noeske; Gregory S Basarab; Erin Code; Andrew D Ferguson; Ning Gao; Jian Huang; Manuel F Juette; Stephania Livchak; Matthew D Miller; D Bryan Prince; Jamie H D Cate; Ed T Buurman; Scott C Blanchard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 2.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

3.  The antibiotics market.

Authors:  Bashar Hamad
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

4.  Pharmacokinetics and safety of CXA-101, a new antipseudomonal cephalosporin, in healthy adult male and female subjects receiving single- and multiple-dose intravenous infusions.

Authors:  Yigong Ge; M J Whitehouse; Ian Friedland; George H Talbot
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

Review 5.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

Authors:  David Brown
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 84.694

6.  Effective photodynamic therapy against microbial populations in human deep tissue abscess aspirates.

Authors:  Constantine G Haidaris; Thomas H Foster; David L Waldman; Edward J Mathes; Joanne McNamara; Timothy Curran
Journal:  Lasers Surg Med       Date:  2013-08-29       Impact factor: 4.025

7.  Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria.

Authors:  Victor I Band; Chris Ibegbu; Surinder Pal Kaur; Stephanie M Cagle; Ronald Trible; Crystal L Jones; Yun F Wang; Colleen S Kraft; Susan M Ray; Jens Wrammert; David S Weiss
Journal:  J Antimicrob Chemother       Date:  2014-02-28       Impact factor: 5.790

8.  Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.

Authors:  Neil R Stokes; Helena B Thomaides-Brears; Stephanie Barker; James M Bennett; Joanne Berry; Ian Collins; Lloyd G Czaplewski; Vicki Gamble; Paul Lancett; Alastair Logan; Christopher J Lunniss; Hilary Peasley; Stéphanie Pommier; Daniel Price; Carol Smee; David J Haydon
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  A scaffold hopping strategy to generate new aryl-2-amino pyrimidine MRSA biofilm inhibitors.

Authors:  Alexander W Weig; Samantha L Barlock; Patrick M O'Connor; Orry M Marciano; Richard Smith; Robert K Ernst; Roberta J Melander; Christian Melander
Journal:  RSC Med Chem       Date:  2020-12-08

10.  The structures of penicillin-binding protein 4 (PBP4) and PBP5 from Enterococci provide structural insights into β-lactam resistance.

Authors:  Thomas M Moon; Éverton D D'Andréa; Christopher W Lee; Alexei Soares; Jean Jakoncic; Charlene Desbonnet; Monica Garcia-Solache; Lou B Rice; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.